Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase

Background and Aims: HCC risk in chronic hepatitis B (CHB) is higher in the indeterminate phase compared with the inactive phase. However, it is unclear if antiviral therapy reduces HCC risk in this population. We aimed to evaluate the association between antiviral therapy and HCC risk in the indete...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Hepatology (Baltimore, Md.) Ročník 78; číslo 5; s. 1558 - 1568
Hlavní autori: Huang, Daniel Q., Tran, Andrew, Yeh, Ming-Lun, Yasuda, Satoshi, Tsai, Pei-Chien, Huang, Chung-Feng, Dai, Chia Yen, Ogawa, Eiichi, Ishigami, Masatoshi, Ito, Takanori, Kozuka, Ritsuzo, Enomoto, Masaru, Suzuki, Takanori, Yoshimaru, Yoko, Preda, Carmen M., Marin, Raluca I., Sandra, Irina, Tran, Sally, Quek, Sabrina X.Z., Khine, Htet Htet Toe Wai, Itokawa, Norio, Atsukawa, Masanori, Uojima, Haruki, Watanabe, Tsunamasa, Takahashi, Hirokazu, Inoue, Kaori, Maeda, Mayumi, Hoang, Joseph K., Trinh, Lindsey, Barnett, Scott, Cheung, Ramsey, Lim, Seng Gee, Trinh, Huy N., Chuang, Wan-Long, Tanaka, Yasuhito, Toyoda, Hidenori, Yu, Ming-Lung, Nguyen, Mindie H.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Hagerstown, MD Lippincott Williams & Wilkins 01.11.2023
Predmet:
ISSN:0270-9139, 1527-3350, 1527-3350
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Buďte prvý, kto okomentuje tento záznam!
Najprv sa musíte prihlásiť.